UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026906
Receipt number R000030868
Scientific Title Foveal Microstructure Analysis in Eyes with Diabetic Macular Edema Treated with Vitrectomy
Date of disclosure of the study information 2017/04/10
Last modified on 2017/04/08 16:03:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Foveal Microstructure Analysis in Eyes with Diabetic Macular Edema Treated with Vitrectomy

Acronym

Foveal Microstructure Analysis in Eyes with DME Treated with Vitrectomy

Scientific Title

Foveal Microstructure Analysis in Eyes with Diabetic Macular Edema Treated with Vitrectomy

Scientific Title:Acronym

Foveal Microstructure Analysis in Eyes with DME Treated with Vitrectomy

Region

Japan


Condition

Condition

Diabetic macular edema

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the surgical outcome, and factors affecting outcomes after vitrectomy for diabetic macular edema.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Improvement of visual acuity

Key secondary outcomes

Improvement of retinal thickness


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

One year outcome after vitrectomy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients are include having DM and diabetic macular edema.

Key exclusion criteria

Patients are excluded if they had a history of prior scleral buckling and pars plana vitrectomy, and high myopia with a refractive error of greater than -8.0 diopters, severe cataract of higher than grade 3, glaucoma, or type 1 diabetes mellitus, and if macular laser grid and/or panretinal photocoagulation (PRP) and subtenon TA (STTA) had been performed within 3 months before study enrollment.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Jiro Kogo

Organization

St. Marianna University School of Medicine

Division name

Ophthalmology

Zip code


Address

2-16-1 Sugao Miyamae-ku Kawasaki, Kanagawa

TEL

044-977-8111

Email

kogo@marianna-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Jiro Kogo

Organization

St. Marianna University School of Medicine

Division name

Ophthalmology

Zip code


Address

2-16-1 Sugao Miyamae-ku Kawasaki, Kanagawa

TEL

044-977-8111

Homepage URL


Email

kogo@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine
Department of Ophthalmology

Institute

Department

Personal name



Funding Source

Organization

St. Marianna University School of Medicine
Department of Ophthalmology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2017 Year 04 Month 06 Day

Date of IRB


Anticipated trial start date

2017 Year 04 Month 10 Day

Last follow-up date

2018 Year 12 Month 02 Day

Date of closure to data entry

2018 Year 12 Month 31 Day

Date trial data considered complete

2018 Year 12 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 04 Month 08 Day

Last modified on

2017 Year 04 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030868


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name